These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11859144)

  • 21. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
    Tan LJ; Vanderlugt CL; McRae BL; Miller SD
    Autoimmunity; 1998; 27(1):13-28. PubMed ID: 9482204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
    Diab A; Deng C; Smith JD; Hussain RZ; Phanavanh B; Lovett-Racke AE; Drew PD; Racke MK
    J Immunol; 2002 Mar; 168(5):2508-15. PubMed ID: 11859145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Huang YM; Yang JS; Xu LY; Link H; Xiao BG
    Clin Exp Immunol; 2000 Dec; 122(3):437-44. PubMed ID: 11122252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling.
    Fitzgerald DC; Zhang GX; Yu S; Cullimore ML; Zhao Z; Rostami A
    J Neuroimmunol; 2012 Jun; 247(1-2):32-7. PubMed ID: 22522341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11.
    Bebo BF; Adlard K; Schuster JC; Unsicker L; Vandenbark AA; Offner H
    J Neurosci Res; 1999 Feb; 55(4):432-40. PubMed ID: 10723054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
    Kumar V; Stellrecht K; Sercarz E
    J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells.
    Gabrysová L; Wraith DC
    Eur J Immunol; 2010 May; 40(5):1386-95. PubMed ID: 20162554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
    Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
    Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
    Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
    Tran EH; Prince EN; Owens T
    J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
    Cua DJ; Hinton DR; Stohlman SA
    J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
    Miller A; Lider O; Abramsky O; Weiner HL
    Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis.
    Santambrogio L; Crisi GM; Leu J; Hochwald GM; Ryan T; Thorbecke GJ
    J Neuroimmunol; 1995 May; 58(2):211-22. PubMed ID: 7759610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis.
    Pastor S; Minguela A; Mi W; Ward ES
    J Immunol; 2009 May; 182(9):5268-75. PubMed ID: 19380773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.